BioVIE Drops After Phase 2, MSU Leads Hormonal Drug Modeling, Exercise After Cancer Cuts Recurrence, Rochester Leads Global Laser Science, and more...
(0:10): BioVie Shares Drop 16% After Mixed Phase 2 Results for Long COVID Treatment(2:12): $12.8M NIH Grant Boosts Women's Hormonal Drug Modeling Initiative Led by Michigan State University(4:37): Exercise Post-Cancer Treatment Cuts Recurrence, Boosts Survival: Major Study Finds(6:56): Rochester to Lead Global Laser Science with $13.7M NSF Backing for World's Most Powerful Laser Facility(9:06): Study Unveils ATP Synthase's Crucial Role in Calcium Homeostasis Beyond Energy ProductionTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: InvestorsHub
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Science News Daily
Lab Grown Brain Tissue Sparks Debate, Bolivia Unveils Leopardus Tilcayo, New mRNA Flu Vaccine Boosts Immunity, EU Faces Vaccine Crisis, and more...
Little Red Dots Map Black Hole Growth, 2026 Breakthroughs Announced, Ctenophores Unlock Nervous System Secrets, DNA Markers Boost Crop Resilience, and more...
Quantum Breakthrough Teleports 100 Channels, LHC Probes Entangled Z Bosons, Karikó Wins Nobel After 40 Years, New Embryo Mechanism Reveals Heart Defects, and more...
Tagrisso Cuts Lung Cancer Deaths, CERN Simulates Cosmic Rays, Glioblastoma Breakthrough Unite, Deaf People Gain Peripheral Vision, and more...
Get summaries like this every morning.
Free AI-powered recaps of Science News Daily and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.